Treatment

Since 2007, the guideline development process within the WHO has been overseen by the WHO Guidelines Review Committee (GRC), which follows internationally recognized standards such as the GRADE approach [Grading of Recommendations Assessment, Development, and Evaluation], to support a structured and transparent methodology for policy-making. The policy recommendations presented in the guideline document were developed following the standards and updated procedures as described in the WHO Handbook for Guideline Development.

Notes:

1. Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 update (WHO/HTM/TB/2011.6). Geneva: World Health Organization; 2011 (https://www.who.int/tb/areas-of-work/drug-resistant-tb/programmatic_guidelines_for_mdrtb/en/).
2. Guidelines for treatment of drug-susceptible tuberculosis and patient care – 2017 update (WHO/HTM/TB/2017.05).

The GDGs discussed research priorities and highlighted a number of priorities.

Recommendations 3.1–3.2

Remarks

Recommendations 2.1–2.2

Justification